Oxytocin release after bleeding in rat: The role of sympathetic and renin-angiotensin system

Journal of Physiology and Pharmacology

Volumn 57, Issue 4, 2006, Pages 627-636

  Lipińska, Stanisława ^a   Zebrowska Badalla, A ^a   Lipinska J ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Bleeding; Oxytocin; Renin angiotensin system; Superior cervical ganglion

Indexed keywords

CAPTOPRIL; OXYTOCIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; DENERVATION; DRUG EFFECT; FEMALE; MALE; MOUSE; NONHUMAN; OXYTOCIN RELEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUPERIOR CERVICAL GANGLIONECTOMY; SYMPATHETIC INNERVATION;

ANIMALS; FEMALE; HEMORRHAGE; MALE; MICRODIALYSIS; OXYTOCIN; RADIOIMMUNOASSAY; RATS; RATS, INBRED STRAINS; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 33846199177     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Vandesande F, Derickx K, De Mey J. Identification of the vasopressin-neurophysin producing neurons of the rat suprachiasmatic nuclei. Cell Tis Res 1975; 156:377-380.
2. Swaab DF, Pool CW, Nijevelt F. Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophysial system. J Neurol Transm 1975; 36:195-215.
3. Buijs RM. Vasopressin and oxytocon - their role in neurotransission. Pharmac Ther 1983; 22:127-141.
4. Langraf R, Malkinson T, Horn T, Veale WL, Lederis K, Pittman QJ. Release of vasopressin and oxytocin by paraventricular stimulation in rats. Am J Physiol 1990; 258:R155-159.
5. McCann SM, Gutkowska J, Antunes-Rodrigues J. Neuroendocrine control of body fluid homeostasis. Braz J Med Biol Res 2003; 36: 165-181.
6. Poulin P, Kormulainen A, Takahashi Y, Pittman QJ. Enhanced pressor responses to IVC vasopressin after pretritment with oxytocin. Am J Physiol 1994; 266: R592-598.
7. Callahan MF, Kirby RF, Cunninham JR, Eskridge-Sloop SL, Johnson AK, McCarty R, Gruber KA. Central oxytocin system may mediate a cardiovascular response to acute stress in rats. Am J Physiol 1989; 256:H1369-1377.
8. Lucion AB, Li P, Callahan MF, Morris M. Central oxytocin mediates stress-induced tachycardia. FASEB J 1995; 9(3): A293-298.
9. Morris M, Callahan MF, Li P, Lucion AB. Central oxytocin mediates stress-induced tachycardia. J Neuroendocrinol 1995; 7:455-459.
10. Russ RD, Walker BR. Oxytocin augments baroreflex bradycardia in conscious rats. Peptides 1994; 15:907-912.
11. Fitts DA, Thornton SN, Ruhf AA, Zierath DK, Johnson AK, Thunhorst RL. Effects of central oxytocin receptor blockade on water and saline intake, mean arterial pressure, and c-Fos expression in rats. Am J Physiol Regul Integr Comp Physiol 2003; 285:R1331-1339.
12. Lipińska S, Rubacha G, Traczyk WZ. The effects of cervical sympathectomy on vasopressin and oxytocin content in rats posterior pituitary lobe. Ann Acad Med Lodz 1980; 21:93-98.
13. Lewandowska A, Głowacka A, Guzek WZ. The vasopressin and oxytocin neurohypophysial content as influenced by bleeding or dehydration: effects of cholecystokinin octapeptide. J Physiol Pharmacol 1992; 43: 153-163.
14. Ciosek J, Cisowska A, Da̧browski R. Galanin affects vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in haemorrhaged rats. J Physiol Pharmacol 2003; 54: 233-246.
15. Kasting NW. Stimultaneous and independent release of vasopressin and oxytocin in the rat. Can J Physiol 1988; 66: 22-26.
16. Lipińska S, Foryś S, Lipińska J. The post-haemorrhagic vasopressin release into the blood. J Physiol Pharmacol 2004; 55: 73-83.
17. Gora̧ca A, Traczyk WZ. Increase in cardiodepressant factor release from the posterior pituitary lobe after angiotensin II infusion into the internal carotid artery. J Physiol Pharmacol 1997; 48: 225-237.
18. Lipińska S. The role of adrenoreceptors in the regulation of oxytocin and vasopressin release after superior cervical ganglionectomy. J Physiol Pharmacol 2000; 51: 111-125.
19. Gora̧ca A. Increase in vasopressin concentration and cardiodepressant activity in the blood dialysates after NMDA and hypertonic saline administration. J Physiol Pharmacol 1998; 49: 561-575.
20. Grzegorzewski W, Skipor J, Wasowska B, Krzymowski T. Courent current transfer of oxytocin from the venous blood of the perihypophyseal cavernous sinus to the arterial blood of carotid rete suppling the hypophysis and brain depends on the phase of the estrous cycle in pigs. Biol Reprod 1995; 52: 139-144.
21. Schadt JC, Ludbrook J. Hemodynamic and neurohormonal responses to acute hypovolemia in conscious mammals. Am J Physiol 1991; 260: H305-318.
22. Fendler K, Endroczi E, Lissak K. The effect of cervical sympathectomy on posterior pituitary oxytocic activity in rats under chronic stress. Acta Physiol Hung 1965; 27:275-278.
23. Fendler K, Vermes I, Stark A, Lissak K. Effect of cervical sympathectomy on the development of "miniature neurohypophysis" and on the neurosecretory nuclei of the hypothalamus after transection of the pituitary stalk. Neuroendocrinology 1970; 6:194-196.
24. Cardinali DP, Vacas MI, Fortis AL, Stefano FJE. Superior cervical ganglionectomy depresses norepinephrine uptake, increases the density of alpha-adrenoceptor site and induces supersensitivity to adrenergic drugs in rat medial basal hypothalamus. Neuroendocrinology 1981; 33: 199-206.
25. Saavedra JM. Central and peripheral catecholamine innervated the rat intermediate and posterior pituitary lobes. Neuroendocrinology 1985; 40: 281-284.
26. Alper RH, Demerest KT, Moore LE. Effects of surgical sympathectomy on catecholamine concentrations in the posterior pituitary of the rat. Experientia 1980; 36: 134-135.
27. Romeo HE, Spinedi E, Esquifino AI, Estivaritz F, Cardinali DP. Anterograde nerve degeneration after superior cervical ganglionectomy coexists with a decrease of arginine vasopressin release in rats. Neuroendocrinology 1991; 54: 346-352.
28. Emmelin N, Trandelenburg U. Degeneration activity after parasympathetic or sympathetic denervation. Rev Physiol Biochem Exp Pharmacol 1972; 66: 148-204.
29. Juszczak M, Guzek JW, Lewy A. The influence of melatonin on the content of vasopressin and oxytocin in the hypothalamus and neurohypophysis in euhydrated and dehydrated male rats. J Pineal Res 1986; 3: 199-211.
30. Juszczak M, Guzek JW. The hypothalamic and neurohypophysial vasopressin and oxytocin in melatonin-treated pinealectomized male rats. J Pineal Res 1988; 5: 545-552.
31. Dawson CA, Jhamandas JH, Krukoff TL. Activation by systemic angiotensin II of neurochemically identified neurons in rat hypothalamic paraventricular nucleus. J Neuroendocrinol 1998; 10: 453-459.
32. Chiodera P, Volpi R, Caiazza A, Giuliani N, Magotti MG, Coiro V. Arginine vasopressin and oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men. Metabolism 1998; 47: 893-896.
33. Bealer SL, Crowley WR. Angiotensin II-induced release of oxytocin: interaction with norepinephrine and role in lactation. Regul Pept 2003; 111: 41-46.
34. Roesch DM, Blackburn-Munro RE, Verbalis JG. Mineralocorticoid treatment attenuates activation of oxytocinergic and vasopressinergic neurons by icv AnG II. Am J Physio Regul Intrgr Comp Physiol 2001; 280: R1853-1864.
35. Kadekaro M, Terrell ML, Bui V, Summy-Long JY. Central interactions between angiotensin II and PGD(2) in the regulation of vasopressin and oxytocin secretion in dehydrated rats. Brain Res 2001; 889: 84-88.
36. Griendling KK, Mineri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-1148.
37. Wolf G, Ziyadeh FN, Schroeder R, Stahl RA. Angiotensin II inhibits inducible nitric oxide synthase in tubular MCT cells by a posttranscriptional mechanism. J Am Soc Nephrol 1997; 8: 551-557.
38. Pastore L, Tessitore A, Martinotti S, et al.Angiotensin II stimulates intracellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 1999; 100: 1646-1652.
39. Vaughan DE. Angiotensin and vascular fibrynolytic balance. Am J Hyperten 2002; 15:3S-8S.
40. Kubo-Inoue M, Egashira K, Usui M, et. al. Long-term inhibition of nitric oxide synthesis increases arterial thrombogenicity in rat carotid artery. Am J Physiol Heart Circ Physiol 2002; 282: H1478-1484.
41. Kamińska M, Mogielnicki A, Stankiewicz A, et. al. Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats. J Physiol Pharmacol 2005; 56: 571-585.
42. Wojewódzka-Żelezniakowicz M, Chabielska E, Mogielnicki A, et al. Antithrombic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats. J Physiol Pharmacol 2006; 57: 231-245.
43. Nishimura H, Tsuji H, Masuda H, et al. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost 1997; 1189-1195.